Trial Profile
Human Factors Study for the Evaluation of the Methotrexate Prefilled Pen (50 mg/mL) for Subcutaneous Injection in Pediatric and Adolescent Patients With Juvenile Idiopathic Arthritis
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 02 Apr 2018
Price :
$35
*
At a glance
- Drugs Methotrexate (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Medac
- 26 Jan 2015 Status changed from not yet recruiting to completed, as reported by ClinicalTrials.gov.
- 07 Feb 2014 New trial record